Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

What Does China's Price Manipulation Ruling On Unilever Mean For Global Pharma? (Part 1 of 2)

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - The National Development and Reform Commission, China's state planning agency, charged consumer goods company Unilever a fine of RMB 2 million ($310,000) for price manipulation May 6. The NDRC action was taken in an effort to suppress consumer inflation, but a key takeaway, according to experts, is that multinational companies should be cautious about how they communicate pricing information to the market or they may find themselves in violation of China's Price Law, Anti-Monopoly Law or even foreign antitrust and anti-bribery rules
Advertisement

Related Content

New Framework Anticipates More Anti-monopoly Cases In China
China’s NDRC Issues Anti-Monopoly Law's Priciest Fine Ever On Two Chinese Firms Manipulating Raw Ingredient Sales
China Tries To Curb Rising TCM Ingredient Prices, But Hikes Persist
China Tries To Curb Rising TCM Ingredient Prices, But Hikes Persist
What Does China's Price Manipulation Ruling On Unilever Mean For Global Pharma? (Part 2 of 2)
What Does China's Price Manipulation Ruling On Unilever Mean For Global Pharma? (Part 2 of 2)
Advertisement
UsernamePublicRestriction

Register

SC077977

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel